Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
Alexandra–Chloé Villani(Broad Institute), Denis Franchimont(McGill University Health Centre), Séverine Vermeire(KU Leuven), Alain Bitton, Joan Wither(Sun Yat-sen University), Catherine Collette(Montreal General Hospital), Mathieu Lemire(Ontario Institute for Cancer Research), Thomas J. Hudson(Ontario Institute for Cancer Research), John D. Rioux(Broad Institute), Édouard Louis(Centre Hospitalier Universitaire de Liège), Marika Sarfati(Université de Montréal), Jacques Bélaïche(Centre Hospitalier Universitaire de Liège), Paul R. Fortin(Toronto Western Hospital), Cécile Libioulle(Centre Hospitalier Universitaire de Liège), Diane Langelier(Centre Hospitalier Universitaire de Sherbrooke), Daniel Gaudet(Brigham and Women's Hospital), Paul Rutgeerts(Universitair Ziekenhuis Leuven), Geneviève Fortin(McGill University Health Centre), Mark S. Silverberg(Mount Sinai Hospital), Albert Cohen(Jewish General Hospital), Nobuyasu Baba(Université de Montréal)
Cited by 523
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.2k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k